NORTHWEST INVESTMENT COUNSELORS, LLC - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 275 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHWEST INVESTMENT COUNSELORS, LLC ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$161,162
-10.5%
4,220
-3.7%
0.04%
-6.2%
Q2 2023$180,149
-28.4%
4,3800.0%0.05%
-31.4%
Q1 2023$251,456
+2.4%
4,3800.0%0.07%
-1.4%
Q4 2022$245,587
+32.0%
4,3800.0%0.07%
+16.4%
Q3 2022$186,000
-21.5%
4,3800.0%0.06%
-16.4%
Q2 2022$237,000
-15.7%
4,3800.0%0.07%
-1.4%
Q1 2022$281,000
-4.1%
4,3800.0%0.07%
+2.8%
Q4 2021$293,000
-2.3%
4,3800.0%0.07%
-14.3%
Q3 2021$300,000
+0.3%
4,3800.0%0.08%
+1.2%
Q2 2021$299,000
-1.3%
4,3800.0%0.08%
-3.5%
Q1 2021$303,000
+6.7%
4,3800.0%0.09%
-2.3%
Q4 2020$284,000
+37.2%
4,3800.0%0.09%
+23.9%
Q3 2020$207,000
+0.5%
4,3800.0%0.07%
-10.1%
Q2 2020$206,000
-19.2%
4,3800.0%0.08%
-12.2%
Q4 2019$255,000
-3.0%
4,3800.0%0.09%
-3.2%
Q3 2019$263,000
+7.3%
4,3800.0%0.09%
+3.3%
Q2 2019$245,000
+0.4%
4,3800.0%0.09%
-4.3%
Q1 2019$244,000
-15.3%
4,380
-31.3%
0.09%
-25.4%
Q4 2018$288,000
-31.4%
6,3800.0%0.13%
-21.7%
Q3 2018$420,000
-7.9%
6,380
-9.9%
0.16%
-12.5%
Q2 2018$456,000
+14.9%
7,080
-1.4%
0.18%
+10.8%
Q1 2018$397,000
+7.3%
7,180
-7.1%
0.17%
+11.4%
Q4 2017$370,000
-5.1%
7,7300.0%0.15%
-11.8%
Q3 2017$390,000
-9.3%
7,730
-1.9%
0.17%
-13.3%
Q2 2017$430,000
+29.5%
7,8800.0%0.20%
+21.9%
Q1 2017$332,000
-1.8%
7,880
+100.0%
0.16%
-6.4%
Q4 2016$338,000
-3.7%
3,940
-7.4%
0.17%
-5.5%
Q3 2016$351,000
+3.5%
4,2550.0%0.18%
-2.2%
Q2 2016$339,000
+18.1%
4,255
-0.2%
0.18%
+13.5%
Q1 2016$287,000
-5.3%
4,263
-4.5%
0.16%
-12.8%
Q4 2015$303,000
+5.2%
4,463
-7.8%
0.19%
-3.6%
Q3 2015$288,000
-13.5%
4,843
-1.9%
0.19%
-5.4%
Q2 2015$333,000
+7.4%
4,939
-1.7%
0.20%
+6.8%
Q1 2015$310,000
+12.7%
5,023
-1.0%
0.19%
+9.1%
Q4 2014$275,000
+7.4%
5,073
-1.5%
0.18%
+2.3%
Q3 2014$256,000
+5.8%
5,149
+0.3%
0.17%
+6.2%
Q2 2014$242,000
+2.5%
5,132
-0.1%
0.16%
-0.6%
Q1 2014$236,000
-3.7%
5,135
+0.1%
0.16%
-4.1%
Q4 2013$245,000
+18.4%
5,1320.0%0.17%
+6.9%
Q3 2013$207,0000.0%5,132
-9.3%
0.16%
-8.1%
Q2 2013$207,0005,6600.17%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q4 2022
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders